Salesforce (CRM) stock was upgraded by analysts who cited the buzz around the tech giant's AI tool, Agentforce.
The new Salesforce platform enables businesses to create and deploy AI tools for a range of tasks like sales, marketing and customer support.
"The positivity around the launch of Agentforce is palpable with customers and with partners," KeyBanc analysts said in a note, according to Barron's.
↑ XSalesforce unveiled Agentforce earlier this year as AI tools, known as agents or copilots, geared toward helping businesses and organizations improve their operations, emerged as a key battleground in AI. The San Francisco-based software behemoth is rolling out Agentforce 2.0 next week.
The quick turnaround underlines the intense competition over AI tools.
Microsoft (MSFT) has touted Copilot as it seeks to boost its position in AI. This week, Alphabet (GOOGL) unveiled a new version of its Gemini 2.0 AI platform which CEO Sundar Pichai said was aimed at the "agentic era."
Salesforce got some upbeat reviews from KeyBanc.
"We are fans of agents over copliots as an AI medium, have had optimistic conversations with partners and wrote recently that Salesforce is in a sweet spot where Agentforce hype does not yet have to lead to tangible revenue," KeyBanc analysts said.
Shares of Salesforce rose 1% in early trades on Friday.
After a bumpy ride in June, Salesforce stock has been on a roll, gaining more than 35% year to date. The stock has climbed above its 50-day average, and is poised to reclaim its 21-day.
CRM stock gapped up 11% to a record high on Dec. 4 following earnings, in part on AI optimism. Shares are just below those levels now.
Salesforce stock has a high Relative Strength Rating of 90, up sharply from 25 six months ago.
YOU MAY ALSO LIKE
IBD Live: A Great Tool For Daily Stock Market Analysis
OpenAI, Anthropic Face Tough AI Showdown With Big Tech. How This Race With Google, Meta Is Playing Out.
Broadcom Stock Soars On Massive AI Chip Opportunity
Palantir, Bitcoin Play Likely To Join Nasdaq 100; Who Will Get The Ax?
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。